Cyclosporin A, but Not Tacrolimus, Inhibits the Biliary Excretion of Mycophenolic Acid Glucuronide Possibly Mediated by Multidrug Resistance-Associated Protein 2 in Rats
Open Access
- 20 February 2004
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 309 (3), 1029-1035
- https://doi.org/10.1124/jpet.103.063073
Abstract
The onset of diarrhea after the administration of mycophenolate mofetil (MMF) is possibly associated with the biliary excretion of its metabolite, mycophenolic acid glucuronide (MPAG). This study was undertaken to clarify the mechanism underlying the biliary excretion of MPAG. Intravenously administered mycophenolic acid (MPA, 5 mg/kg) rapidly disappeared from plasma and was efficiently excreted as MPAG in the bile of Wistar (26% of dose) and Sprague-Dawley rats (21% of dose) over 1 h. On the other hand, in spite of the rapid disappearance of MPA from plasma, the biliary excretion of MPAG was very limited in Eisai hyperbilirubinemic rats (EHBRs), which display mutations in multidrug resistance-associated protein 2 (Mrp2)/canalicular multispecific organic anion transporter, and constituted only 0.5% of dose. Instead, high levels of MPA were noted in the plasma of EHBRs. Intravenous administration of CsA (5 mg/kg) to Wistar rats significantly lowered the biliary excretion of MPAG. However, intravenously administered tacrolimus (0.1 mg/kg) failed to produce such effect. In conclusion, it is suggested that there is an efficient MPAG transport mediated by Mrp2 on the bile canalicular membrane of rat hepatocytes and that the therapeutic range of CsA potentially interferes with Mrp2. However, the therapeutic range of tacrolimus does not inhibit the transporter. Thus, it should be noted that MMF coadministered with tacrolimus instead of CsA might increase the occurrence of diarrhea related to the biliary excretion of MPAG in transplant recipients.Keywords
This publication has 23 references indexed in Scilit:
- Comparison of the Incidence of Diarrhea in Renal Transplant Patients with or without Mycophenolate Mofetil AdministrationIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2003
- Sinusoidal Efflux of Taurocholate Is Enhanced in Mrp2-Deficient Rat LiverPharmaceutical Research, 2001
- Adverse Gastrointestinal Effects of Mycophenolate MofetilDrug Safety, 2001
- Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppressionPediatric Nephrology, 2000
- EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1Transplantation, 1999
- Effect of cyclosporin A or tacrolimus on the function of blood–brain barrier cellsEuropean Journal of Pharmacology, 1999
- Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)Journal of Biological Chemistry, 1999
- Differential effects of jaundice and cirrhosis on β-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathyJournal of Hepatology, 1999
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivativesAnti-Cancer Drugs, 1993